Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

FDA okays Discovery's phase II trial with Surfaxin

Nov. 21, 2000

Recent patent discloses novel compounds particularly useful for asthma and rhinitis

Nov. 17, 2000

Novel tetrahydropyridazines from Merck KGaA inhibit PDE4 and TNF

Nov. 16, 2000

Inhibitors of LFA-1 binding to ICAMs in development at Icos

Nov. 15, 2000

SciClone reformulates CPX for CF

Nov. 14, 2000

Partnership formed for INOmax distribution in Japan

Nov. 13, 2000

FDA advises removal of phenylpropanolamine-containing products

Nov. 13, 2000

Astelin Nasal Spray approved in U.S. for treatment of nonallergic vasomotor rhinitis

Nov. 10, 2000

Copernicus reaches milestone in gene delivery approach to CF

Nov. 10, 2000

Modulators of chemokine CCR receptors claimed in patent literature by AstraZeneca

Nov. 9, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...